Civic Intelligence

Aim-Hi Accelerator Fund Inc.

990 • Fiscal year 2022 • EIN 82-4322538

Jan 01, 2022 to Dec 31, 2022 • Filed on Apr 25, 2023

5515 Security Lane Suite 1105Rockville, MD 20852

(301) 654-1250

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

7th percentile

0.00x

Higher debt load relative to assets than 7% of similar nonprofits.

2022 filings • 501(c)3 • $10M-$25M nonprofits • Source year 2022

Liabilities / Revenue

6th percentile

0.00x

Higher debt load relative to revenue than 6% of similar nonprofits.

2022 filings • 501(c)3 • $10M-$25M nonprofits • Source year 2022

Net Margin

98th percentile

96%

Higher net margin than 98% of similar nonprofits.

2022 filings • 501(c)3 • $10M-$25M nonprofits • Source year 2022

Top Officer Pay

14th percentile

$0

Higher top officer pay than 14% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

2022 filings • 501(c)3 • $10M-$25M nonprofits • Source year 2022

Asset Growth

89th percentile

39%

Faster asset growth than 89% of similar nonprofits.

2022 filings • 501(c)3 • $10M-$25M nonprofits • Annualized from 2021 to 2022

Revenue Growth

69th percentile

17%

Faster revenue growth than 69% of similar nonprofits.

2022 filings • 501(c)3 • $10M-$25M nonprofits • Annualized from 2021 to 2022

Assets

Up

$13,356,814

Up $3,737,092 (+39%) from 2021

Net Assets

Up

$13,349,402

Up $3,730,310 (+39%) from 2021

Liabilities

Up

$7,412

Up $6,782 (+1077%) from 2021

Revenue

Up

$3,905,995

Up $558,272 (+17%) from 2021

Expenses

Up

$175,685

Up $169,161 (+2593%) from 2021

Net Income

Up

$3,730,310

Up $389,111 (+12%) from 2021

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$20M$15M$10M$5.0M$0Assets 2020: $5,739,893Liabilities 2020: $0Net Assets 2020: $5,739,8932020Assets 2021: $9,619,722Liabilities 2021: $630Net Assets 2021: $9,619,0922021Assets 2022: $13,356,814Liabilities 2022: $7,412Net Assets 2022: $13,349,4022022Assets 2023: $14,774,789Liabilities 2023: $4,975Net Assets 2023: $14,769,8142023Assets 2024: $16,114,527Liabilities 2024: $3,083Net Assets 2024: $16,111,4442024

Highlighted filing

2022

Assets$13,356,814
Liabilities$7,412
Net Assets$13,349,402

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$6.0M$4.0M$2.0M$0Revenue 2020: $5,826,730Expenses 2020: $86,837Net Income 2020: $5,739,8932020Revenue 2021: $3,347,723Expenses 2021: $6,524Net Income 2021: $3,341,1992021Revenue 2022: $3,905,995Expenses 2022: $175,685Net Income 2022: $3,730,3102022Revenue 2023: $2,069,894Expenses 2023: $649,482Net Income 2023: $1,420,4122023Revenue 2024: $1,566,732Expenses 2024: $225,102Net Income 2024: $1,341,6302024

Highlighted filing

2022

Revenue$3,905,995
Expenses$175,685
Net Income$3,730,310
Jump To
Filing Snapshot
Filing Period
Jan 1, 2022 to Dec 31, 2022
Signed
Apr 25, 2023
Return Version
2022v5.0
Gross Receipts
$3,905,995
Mission and Program Overview

Mission

The AIM-HI Accelerator Fund is an independent 501(C)(3) non-profit organization, established with an initial grant from the National Foundation for Cancer Research with the vision to accelerate the translation of cancer drug discoveries by investing in seed-stage companies. It is a new paradigm through venture philanthropy to fund start-up oncology companies that commercialize innovative laboratory breakthroughs which can potentially save cancer patients' lives.

Balance Sheet Detail
LineBeginningEndChange
Assets
Investments Program Related$9,230,897$11,680,895▲ $2,449,998
Pledges and Grants Receivable-$1,005,250-
Cash and Non-Interest-Bearing Accounts$388,825$670,669▲ $281,844
Total Assets$9,619,722$13,356,814▲ $3,737,092
Liabilities
Accounts Payable and Accrued Expenses$630$7,412▲ $6,782
Total Liabilities$630$7,412▲ $6,782
Net Assets / Fund Balance
Net Assets Without Donor Restrictions$9,619,092$13,349,402▲ $3,730,310
Net Assets With Donor Restrictions$0$0→ $0
Total Net Assets Fund Balance$9,619,092$13,349,402▲ $3,730,310
Total Liabilities and Net Assets / Fund Balance$9,619,722$13,356,814▲ $3,737,092

Asset Categories

AssetBook ValueDepreciationBasis
Investment Program Related Org$999,999--
Compensation and Service Providers

Board Members and Trustees

NameTitle
Charlie WeatherspoonChairman of the Board
Sujuan BaPresident/CEO
Matt TremblayVice Chairman
Alfred SlanetzDirector
Brian Leyland-jonesDirector
Franklin Salisbury JrDirector
Mark BaranDirector
Yajun XuDirector
Kwok LeungTreasurer/secretary
Revenue and Support

Revenue Composition

Contributions and Grants
$3,905,995
Program Service Revenue
$0
Investment Income
$0
Other Revenue
$0
All Other Contributions
$3,905,995
Change in Net Assets
$3,730,310

Noncash Contribution Practices

Property subject to holding requirements
No
Reviewed unusual noncash gifts
Yes
Third parties used for noncash contributions
No

Noncash Contributions

Contribution TypeContribution CountReported AmountValuation Method
Securities Miscellaneous3$850,000Book Value
Securities Closely Held Stock1$499,999Book Value
Total Noncash Contributions4$1,349,999-
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Other Expenses$140,185
Grants and Similar Amounts Paid$35,500
Total Fundraising Expense$4,676
Professional Fundraising Fees$0
Salaries, Compensation, and Employee Benefits$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Conferences and Meetings$79,143--$79,143
Information Technology-$41,174$4,676$45,850
Grants to Domestic Orgs$35,500--$35,500
Fees for Services Legal-$11,968-$11,968
Advertising-$1,600-$1,600
Travel$1,538--$1,538
Office Expenses-$86-$86
Total Functional Expenses$116,181$54,828$4,676$175,685
International Activity

Grant and Assistance Recipients

RecipientLocationCategoryPurposeAmount
Beliver Pharmaceuticals IncWilmington, DE-Cancer Research$10,000
Riverwalk Therapeutics IncHelotes, TX-Cancer Research$10,000
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Backup withholding compliance
Yes
Business relationship with 35% controlled entity
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
Yes
Other officer compensation reviewed
Yes
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section A, Line 2

Board director franklin salisbury, jr. And ceo sujuan ba are husband and wife.

Form 990, Part VI, Section A, Line 7A

As the incorporator and the initial granter to the organization, national foundation for cancer research (nfcr) has the power to appoint up to two (2) directors to the governing body. The appointees will never constitute more than forty (40) percent of all voting power.

Form 990, Part VI, Section B, Line 11B

Review process of form 990: (1) form 990 will be prepared by the treasurer after the annual financial statements are done; (2) the first draft will be reviewed by the ceo, (3) after resolving any questions or updates, the revised draft will be sent to the board of directors, preferably electronically for their respective review and comments, (4) the comments from board of directors, if any, will be incorporated in the final return, (5) the tax return (form 990 or equivalent) will be filed with the internal revenue service prior to the designated due date or extended due date. (6) in the occassion that there is insufficient time prior to filing form 990 to share it with the board, or there is absence of an opportunity for any meaningful review by the board prior to the filing deadline, an filed copy of the form will be available for board of directors' review and comments after submission of return to irs. An amended return, if necessary, will be filed.

Form 990, Part VI, Section B, Line 12C

Conflict of interest policy compliance: each director, prior to taking the position on the board, and all present directors shall submit annually in writing to the board of directors a list of all businesses or other organizations of which he/she is an officer, director, trustee, member, owner shareholder, employee or agent, with which the organization has, or might reasonable in the future enter into, a relationship or a transaction in which the director would have conflicting interest.

Form 990, Part VI, Section B, Line 15

Currently all officers of the organization, including ceo and treasurer, are providing pro bono service to the organization. In the future when the organization is financially capable, the board of directors, on an annual basis, will perform a thorough review to determine suitable compensation for officers. The process includes all of the following three elements: (1) review and approval by the board of directors, based on performance and responsibilities, (2) review of compensation data of the peer organizations of the organization, (3) documentation and recordkeeping comparable with respect to the deliberations and decisions regarding the compensation agreement, are kept by the secretary of the organization.

Form 990, Part VI, Section C, Line 19

The organization makes its governing documents, conflict of interest policy, and financial statements available to the public upon request.

Filing and Contact Details

Filer

Filer Name
Aim-hi Accelerator Fund Inc
EIN
82-4322538
Phone
3016541250
Address
5515 SECURITY LANE SUITE 1105, ROCKVILLE, MD 20852
Doing Business As
Aim Hi Translational Research Inc

Signing Officer

Name
Kwok Leung
Title
CFO
Phone
3019619115
Signed
2023-04-25

Organization Details

Principal Officer
Sujuan Ba
Formed
2019
Legal Domicile
Md
Voting Board Members
7
Independent Board Members
7
Employees
0
Volunteers
10
Raw XML AppendixShowing 400 of 445 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt0630
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt07412
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0The AIM-HI Accelerator Fund is an independent 501(C)(3) non-profit organization, established with an initial grant from the National Foundation for Cancer Research with the vision to accelerate the translation of cancer drug discoveries by investing in seed-stage companies. It is a new paradigm through venture philanthropy to fund start-up oncology companies that commercialize innovative laboratory breakthroughs which can potentially save cancer patients' lives.
IRS990/AdvertisingGrp/ManagementAndGeneralAmt01600
IRS990/AdvertisingGrp/TotalAmt01600
IRS990/AllOtherContributionsAmt03905995
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/BackupWthldComplianceInd01
IRS990/BooksInCareOfDetail/PersonNm0Kwok Leung
IRS990/BooksInCareOfDetail/PhoneNum03019619115
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt05515 SECURITY LANE SUITE 1105
IRS990/BooksInCareOfDetail/USAddress/CityNm0ROCKVILLE
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0MD
IRS990/BooksInCareOfDetail/USAddress/ZIPCd020852
IRS990/BusinessRlnWith35CtrlEntInd00
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOrgMemInd00
IRS990/CashNonInterestBearingGrp/BOYAmt0388825
IRS990/CashNonInterestBearingGrp/EOYAmt0670669
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt00
IRS990/CollectionsOfArtInd00
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd01
IRS990/CompensationProcessOtherInd01
IRS990/ConferencesMeetingsGrp/ProgramServicesAmt079143
IRS990/ConferencesMeetingsGrp/TotalAmt079143
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd00
IRS990/ContriRptFundraisingEventAmt00
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt03905995
IRS990/CYGrantsAndSimilarPaidAmt035500
IRS990/CYInvestmentIncomeAmt00
IRS990/CYOtherExpensesAmt0140185
IRS990/CYOtherRevenueAmt00
IRS990/CYProgramServiceRevenueAmt00
IRS990/CYRevenuesLessExpensesAmt03730310
IRS990/CYSalariesCompEmpBnftPaidAmt00
IRS990/CYTotalExpensesAmt0175685
IRS990/CYTotalFundraisingExpenseAmt04676
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt03905995
IRS990/DecisionsSubjectToApprovaInd00
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd01
IRS990/DelegationOfMgmtDutiesInd00
IRS990/Desc0Leveraging immediately deployable venture philanthropy funding to provide seed funding and sustainable impact investment for oncology start-ups to bridge the "Valley of Death" funding gap and bring innovative new therapies, diagnostics and cancer prevention to patients.
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd00
IRS990/DocumentRetentionPolicyInd01
IRS990/DoingBusinessAsName/BusinessNameLine1Txt0AIM HI TRANSLATIONAL RESEARCH INC
IRS990/DonatedServicesAndUseFcltsAmt00
IRS990/DonorAdvisedFundInd00
IRS990/DonorRestrictionNetAssetsGrp/BOYAmt00
IRS990/DonorRestrictionNetAssetsGrp/EOYAmt00
IRS990/DonorRstrOrQuasiEndowmentsInd00
IRS990/ElectionOfBoardMembersInd01
IRS990/EmployeeCnt00
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt0116181
IRS990/FamilyOrBusinessRlnInd01
IRS990/FederalGrantAuditRequiredInd00
IRS990/FederatedCampaignsAmt00
IRS990/FeesForServicesLegalGrp/ManagementAndGeneralAmt011968
IRS990/FeesForServicesLegalGrp/TotalAmt011968
IRS990/FeesForServicesOtherGrp/TotalAmt00
IRS990/ForeignActivitiesInd00
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignOfficeInd00
IRS990/Form1098CFiledInd00
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form8899Filedind00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt02.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt11.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt21.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt31.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt41.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt51.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt61.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt712
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt812
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd5X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd6X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt50
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt60
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt70
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt80
IRS990/Form990PartVIISectionAGrp/PersonNm0CHARLIE WEATHERSPOON
IRS990/Form990PartVIISectionAGrp/PersonNm1MATT TREMBLAY
IRS990/Form990PartVIISectionAGrp/PersonNm2FRANKLIN SALISBURY JR
IRS990/Form990PartVIISectionAGrp/PersonNm3MARK BARAN
IRS990/Form990PartVIISectionAGrp/PersonNm4YAJUN XU
IRS990/Form990PartVIISectionAGrp/PersonNm5BRIAN LEYLAND-JONES
IRS990/Form990PartVIISectionAGrp/PersonNm6ALFRED SLANETZ
IRS990/Form990PartVIISectionAGrp/PersonNm7SUJUAN BA
IRS990/Form990PartVIISectionAGrp/PersonNm8KWOK LEUNG
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt80
IRS990/Form990PartVIISectionAGrp/TitleTxt0CHAIRMAN OF THE BOARD
IRS990/Form990PartVIISectionAGrp/TitleTxt1VICE CHAIRMAN
IRS990/Form990PartVIISectionAGrp/TitleTxt2DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt3DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt4DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt5DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt6DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt7PRESIDENT/CEO
IRS990/Form990PartVIISectionAGrp/TitleTxt8TREASURER/SECRETARY
IRS990/Form990ProvidedToGvrnBodyInd01
IRS990/FormationYr02019
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedInd00
IRS990/FundraisingActivitiesInd00
IRS990/FundraisingAmt00
IRS990/GainOrLossGrp/OtherAmt00
IRS990/GainOrLossGrp/SecuritiesAmt00
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt07
IRS990/GovernmentGrantsAmt00
IRS990/GrantAmt035500
IRS990/GrantsToDomesticOrgsGrp/ProgramServicesAmt035500
IRS990/GrantsToDomesticOrgsGrp/TotalAmt035500
IRS990/GrantsToIndividualsInd00
IRS990/GrantsToOrganizationsInd01
IRS990/GrantToRelatedPersonInd00
IRS990/GrossReceiptsAmt03905995
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd00
IRS990/IndependentAuditFinclStmtInd00
IRS990/IndependentVotingMemberCnt07
IRS990/IndivRcvdGreaterThan100KCnt00
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InformationTechnologyGrp/FundraisingAmt04676
IRS990/InformationTechnologyGrp/ManagementAndGeneralAmt041174
IRS990/InformationTechnologyGrp/TotalAmt045850
IRS990/InvestmentExpenseAmt00
IRS990/InvestmentInJointVentureInd00
IRS990/InvestmentsProgramRelatedGrp/BOYAmt09230897
IRS990/InvestmentsProgramRelatedGrp/EOYAmt011680895
IRS990/IRPDocumentCnt02
IRS990/IRPDocumentW2GCnt00
IRS990/LegalDomicileStateCd0MD
IRS990/LoanOutstandingInd00
IRS990/LobbyingActivitiesInd00
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembershipDuesAmt00
IRS990/MembersOrStockholdersInd00
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd01
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0The AIM-HI Accelerator Fund is an independent 501(C)(3) non-profit organization, established with an initial grant from the National Foundation for Cancer Research with the vision to accelerate the translation of cancer drug discoveries by investing in seed-stage companies. It is a new paradigm through venture philanthropy to fund start-up oncology companies that commercialize innovative laboratory breakthroughs which can potentially save cancer patients' lives.
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd00
IRS990/NetAssetsOrFundBalancesBOYAmt09619092
IRS990/NetAssetsOrFundBalancesEOYAmt013349402
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NetUnrlzdGainsLossesInvstAmt00
IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt09619092
IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt013349402
IRS990/NoListedPersonsCompensatedInd0X
IRS990/NoncashContributionsAmt01349999
IRS990/NondeductibleContributionsInd00
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt086
IRS990/OfficeExpensesGrp/TotalAmt086
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsFASB117Ind0X
IRS990/OtherChangesInNetAssetsAmt00
IRS990/OtherRevenueTotalAmt00
IRS990/PartialLiquidationInd00
IRS990/PayPremiumsPrsnlBnftCntrctInd00
IRS990/PledgesAndGrantsReceivableGrp/EOYAmt01005250
IRS990/PoliticalCampaignActyInd00
IRS990/PrincipalOfficerNm0SUJUAN BA
IRS990/PriorPeriodAdjustmentsAmt00
IRS990/ProfessionalFundraisingInd00
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt03347719
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt00
IRS990/PYInvestmentIncomeAmt04
IRS990/PYOtherExpensesAmt06524
IRS990/PYOtherRevenueAmt00
IRS990/PYProgramServiceRevenueAmt00
IRS990/PYRevenuesLessExpensesAmt03341199
IRS990/PYSalariesCompEmpBnftPaidAmt00
IRS990/PYTotalExpensesAmt06524
IRS990/PYTotalProfFndrsngExpnsAmt00
IRS990/PYTotalRevenueAmt03347723
IRS990/QuidProQuoContributionsInd00
IRS990/RcvFndsToPayPrsnlBnftCntrctInd00
IRS990/ReconcilationRevenueExpnssAmt03730310
IRS990/RegularMonitoringEnfrcInd01
IRS990/RelatedEntityInd00
IRS990/RelatedOrganizationCtrlEntInd00
IRS990/RelatedOrganizationsAmt00
IRS990/RentalIncomeOrLossGrp/PersonalAmt00
IRS990/RentalIncomeOrLossGrp/RealAmt00
IRS990/ReportInvestmentsOtherSecInd00
IRS990/ReportLandBuildingEquipmentInd00
IRS990/ReportOtherAssetsInd00
IRS990/ReportOtherLiabilitiesInd00
IRS990/ReportProgramRelatedInvstInd01
IRS990/RevenueAmt00
IRS990ScheduleA/First5Years170Ind0X
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt03905995
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt03345219
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt05812621
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt013063835
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus1YearAmt04
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus2YearsAmt014109
IRS990ScheduleA/GrossInvestmentIncome170Grp/TotalAmt014113
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportTotal170Amt013063835
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt03905995
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt03345219
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt05812621
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt00
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt00
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt013063835
IRS990ScheduleA/TotalSupportAmt013077948
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990/ScheduleBRequiredInd01
IRS990ScheduleD/InvstProgramRelatedOrgGrp/BookValueAmt01748000
IRS990ScheduleD/InvstProgramRelatedOrgGrp/BookValueAmt11267500
IRS990ScheduleD/InvstProgramRelatedOrgGrp/BookValueAmt2500000
IRS990ScheduleD/InvstProgramRelatedOrgGrp/BookValueAmt31000000
IRS990ScheduleD/InvstProgramRelatedOrgGrp/BookValueAmt4310332
IRS990ScheduleD/InvstProgramRelatedOrgGrp/BookValueAmt5267566
IRS990ScheduleD/InvstProgramRelatedOrgGrp/BookValueAmt61037500
IRS990ScheduleD/InvstProgramRelatedOrgGrp/BookValueAmt7300000
IRS990ScheduleD/InvstProgramRelatedOrgGrp/BookValueAmt8700000
IRS990ScheduleD/InvstProgramRelatedOrgGrp/BookValueAmt9500000
IRS990ScheduleD/InvstProgramRelatedOrgGrp/BookValueAmt10400000
IRS990ScheduleD/InvstProgramRelatedOrgGrp/BookValueAmt11500000
IRS990ScheduleD/InvstProgramRelatedOrgGrp/BookValueAmt12999998
IRS990ScheduleD/InvstProgramRelatedOrgGrp/BookValueAmt13600000
IRS990ScheduleD/InvstProgramRelatedOrgGrp/BookValueAmt14250000
IRS990ScheduleD/InvstProgramRelatedOrgGrp/BookValueAmt15300000
IRS990ScheduleD/InvstProgramRelatedOrgGrp/BookValueAmt16999999
IRS990ScheduleD/InvstProgramRelatedOrgGrp/Desc0INTERLEUKIN COMBINATORIAL THERAPEUTICS INC
IRS990ScheduleD/InvstProgramRelatedOrgGrp/Desc1INVAMET THERAPEUTICS INC
IRS990ScheduleD/InvstProgramRelatedOrgGrp/Desc2ONCOHEROES BIOSCIENCES INC
IRS990ScheduleD/InvstProgramRelatedOrgGrp/Desc3RASIO THERAPEUTICS
IRS990ScheduleD/InvstProgramRelatedOrgGrp/Desc4SCITECH DEVELOPMENT LLC
IRS990ScheduleD/InvstProgramRelatedOrgGrp/Desc5AKROTOME IMAGING INC
IRS990ScheduleD/InvstProgramRelatedOrgGrp/Desc6STROMATIS PHARMA
IRS990ScheduleD/InvstProgramRelatedOrgGrp/Desc7PRIVO TECHNOLOGIES
IRS990ScheduleD/InvstProgramRelatedOrgGrp/Desc8WINDOW THERAPEUTICS
IRS990ScheduleD/InvstProgramRelatedOrgGrp/Desc9TVARDI THERAPEUTICS
IRS990ScheduleD/InvstProgramRelatedOrgGrp/Desc10TELLBIO INC
IRS990ScheduleD/InvstProgramRelatedOrgGrp/Desc11CATALIO GENESIS FUND
IRS990ScheduleD/InvstProgramRelatedOrgGrp/Desc12SPOROS BIOVENTURES LLC
IRS990ScheduleD/InvstProgramRelatedOrgGrp/Desc13YIVIVA INC
IRS990ScheduleD/InvstProgramRelatedOrgGrp/Desc14DOT-BIO PTE LTD
IRS990ScheduleD/InvstProgramRelatedOrgGrp/Desc15ARBELE INVESTMENT LIMITED
IRS990ScheduleD/InvstProgramRelatedOrgGrp/Desc16DRIVER BIO (CHIMERA)
IRS990ScheduleD/InvstProgramRelatedOrgGrp/MethodValuationCd0C
IRS990ScheduleD/InvstProgramRelatedOrgGrp/MethodValuationCd1C
IRS990ScheduleD/InvstProgramRelatedOrgGrp/MethodValuationCd2C
IRS990ScheduleD/InvstProgramRelatedOrgGrp/MethodValuationCd3C
IRS990ScheduleD/InvstProgramRelatedOrgGrp/MethodValuationCd4C
IRS990ScheduleD/InvstProgramRelatedOrgGrp/MethodValuationCd5C
IRS990ScheduleD/InvstProgramRelatedOrgGrp/MethodValuationCd6C
IRS990ScheduleD/InvstProgramRelatedOrgGrp/MethodValuationCd7C
IRS990ScheduleD/InvstProgramRelatedOrgGrp/MethodValuationCd8C
IRS990ScheduleD/InvstProgramRelatedOrgGrp/MethodValuationCd9C
IRS990ScheduleD/InvstProgramRelatedOrgGrp/MethodValuationCd10C
IRS990ScheduleD/InvstProgramRelatedOrgGrp/MethodValuationCd11C
IRS990ScheduleD/InvstProgramRelatedOrgGrp/MethodValuationCd12C
IRS990ScheduleD/InvstProgramRelatedOrgGrp/MethodValuationCd13C
IRS990ScheduleD/InvstProgramRelatedOrgGrp/MethodValuationCd14C
IRS990ScheduleD/InvstProgramRelatedOrgGrp/MethodValuationCd15C
IRS990ScheduleD/InvstProgramRelatedOrgGrp/MethodValuationCd16C
IRS990ScheduleD/TotalBookValueProgramRltdAmt011680895
IRS990ScheduleI/GrantRecordsMaintainedInd01
IRS990ScheduleI/RecipientTable/CashGrantAmt010000
IRS990ScheduleI/RecipientTable/CashGrantAmt110000
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt0CANCER RESEARCH
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt1CANCER RESEARCH
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt0RIVERWALK THERAPEUTICS INC
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt1BELIVER PHARMACEUTICALS INC
IRS990ScheduleI/RecipientTable/RecipientEIN0853970842
IRS990ScheduleI/RecipientTable/RecipientEIN1850881233
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt08511 Mantano Ridge
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt1704 N King St
IRS990ScheduleI/RecipientTable/USAddress/AddressLine2Txt0Ste 500
IRS990ScheduleI/RecipientTable/USAddress/CityNm0Helotes
IRS990ScheduleI/RecipientTable/USAddress/CityNm1Wilmington
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd0TX
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd1DE
IRS990ScheduleI/RecipientTable/USAddress/ZIPCd078023
IRS990ScheduleI/RecipientTable/USAddress/ZIPCd119801
IRS990ScheduleI/SupplementalInformationDetail/ExplanationTxt0Grant recipients are required to submit annual progress reports to our organization.
IRS990ScheduleI/SupplementalInformationDetail/FormAndLineReferenceDesc0Schedule I, Part I, Line 2
IRS990ScheduleI/Total501c3OrgCnt00
IRS990ScheduleI/TotalOtherOrgCnt02
IRS990/ScheduleJRequiredInd00
IRS990ScheduleM/AnyPropertyThatMustBeHeldInd00
IRS990ScheduleM/Form8283ReceivedCnt00
IRS990ScheduleM/ReviewProcessUnusualNCGiftsInd01
IRS990ScheduleM/SecuritiesCloselyHeldStockGrp/ContributionCnt01
IRS990ScheduleM/SecuritiesCloselyHeldStockGrp/MethodOfDeterminingRevenuesTxt0BOOK VALUE
IRS990ScheduleM/SecuritiesCloselyHeldStockGrp/NonCashCheckboxInd0X
IRS990ScheduleM/SecuritiesCloselyHeldStockGrp/NoncashContributionsRptF990Amt0499999
IRS990ScheduleM/SecuritiesMiscellaneousGrp/ContributionCnt03
IRS990ScheduleM/SecuritiesMiscellaneousGrp/MethodOfDeterminingRevenuesTxt0BOOK VALUE
IRS990ScheduleM/SecuritiesMiscellaneousGrp/NonCashCheckboxInd0X
IRS990ScheduleM/SecuritiesMiscellaneousGrp/NoncashContributionsRptF990Amt0850000
IRS990ScheduleM/ThirdPartiesUsedInd00
IRS990/ScheduleORequiredInd01
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0BOARD DIRECTOR FRANKLIN SALISBURY, JR. AND CEO SUJUAN BA ARE HUSBAND AND WIFE.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1AS THE INCORPORATOR AND THE INITIAL GRANTER TO THE ORGANIZATION, NATIONAL FOUNDATION FOR CANCER RESEARCH (NFCR) HAS THE POWER TO APPOINT UP TO TWO (2) DIRECTORS TO THE GOVERNING BODY. THE APPOINTEES WILL NEVER CONSTITUTE MORE THAN FORTY (40) PERCENT OF ALL VOTING POWER.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2REVIEW PROCESS OF FORM 990: (1) FORM 990 WILL BE PREPARED BY THE TREASURER AFTER THE ANNUAL FINANCIAL STATEMENTS ARE DONE; (2) THE FIRST DRAFT WILL BE REVIEWED BY THE CEO, (3) AFTER RESOLVING ANY QUESTIONS OR UPDATES, THE REVISED DRAFT WILL BE SENT TO THE BOARD OF DIRECTORS, PREFERABLY ELECTRONICALLY FOR THEIR RESPECTIVE REVIEW AND COMMENTS, (4) THE COMMENTS FROM BOARD OF DIRECTORS, IF ANY, WILL BE INCORPORATED IN THE FINAL RETURN, (5) THE TAX RETURN (FORM 990 OR EQUIVALENT) WILL BE FILED WITH THE INTERNAL REVENUE SERVICE PRIOR TO THE DESIGNATED DUE DATE OR EXTENDED DUE DATE. (6) IN THE OCCASSION THAT THERE IS INSUFFICIENT TIME PRIOR TO FILING FORM 990 TO SHARE IT WITH THE BOARD, OR THERE IS ABSENCE OF AN OPPORTUNITY FOR ANY MEANINGFUL REVIEW BY THE BOARD PRIOR TO THE FILING DEADLINE, AN FILED COPY OF THE FORM WILL BE AVAILABLE FOR BOARD OF DIRECTORS' REVIEW AND COMMENTS AFTER SUBMISSION OF RETURN TO IRS. AN AMENDED RETURN, IF NECESSARY, WILL BE FILED.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3CONFLICT OF INTEREST POLICY COMPLIANCE: EACH DIRECTOR, PRIOR TO TAKING THE POSITION ON THE BOARD, AND ALL PRESENT DIRECTORS SHALL SUBMIT ANNUALLY IN WRITING TO THE BOARD OF DIRECTORS A LIST OF ALL BUSINESSES OR OTHER ORGANIZATIONS OF WHICH HE/SHE IS AN OFFICER, DIRECTOR, TRUSTEE, MEMBER, OWNER SHAREHOLDER, EMPLOYEE OR AGENT, WITH WHICH THE ORGANIZATION HAS, OR MIGHT REASONABLE IN THE FUTURE ENTER INTO, A RELATIONSHIP OR A TRANSACTION IN WHICH THE DIRECTOR WOULD HAVE CONFLICTING INTEREST.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt4CURRENTLY ALL OFFICERS OF THE ORGANIZATION, INCLUDING CEO AND TREASURER, ARE PROVIDING PRO BONO SERVICE TO THE ORGANIZATION. IN THE FUTURE WHEN THE ORGANIZATION IS FINANCIALLY CAPABLE, THE BOARD OF DIRECTORS, ON AN ANNUAL BASIS, WILL PERFORM A THOROUGH REVIEW TO DETERMINE SUITABLE COMPENSATION FOR OFFICERS. THE PROCESS INCLUDES ALL OF THE FOLLOWING THREE ELEMENTS: (1) REVIEW AND APPROVAL BY THE BOARD OF DIRECTORS, BASED ON PERFORMANCE AND RESPONSIBILITIES, (2) REVIEW OF COMPENSATION DATA OF THE PEER ORGANIZATIONS OF THE ORGANIZATION, (3) DOCUMENTATION AND RECORDKEEPING COMPARABLE WITH RESPECT TO THE DELIBERATIONS AND DECISIONS REGARDING THE COMPENSATION AGREEMENT, ARE KEPT BY THE SECRETARY OF THE ORGANIZATION.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt5THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0Form 990, Part VI, Section A, Line 2
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1Form 990, Part VI, Section A, Line 7a
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2Form 990, Part VI, Section B, Line 11b
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3Form 990, Part VI, Section B, Line 12c
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc4Form 990, Part VI, Section B, Line 15
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc5Form 990, Part VI, Section C, Line 19
IRS990/SchoolOperatingInd00
IRS990/SignificantChangeInd00
IRS990/SignificantNewProgramSrvcInd00
IRS990/SubjectToExcsTaxNetInvstIncInd00
IRS990/SubjectToProxyTaxInd00
IRS990/SubjToTaxRmnrtnExPrchtPymtInd00
IRS990/TaxablePartyNotificationInd00
IRS990/TaxExemptBondsInd00
IRS990/TerminateOperationsInd00
IRS990/TotalAssetsBOYAmt09619722
IRS990/TotalAssetsEOYAmt013356814
IRS990/TotalAssetsGrp/BOYAmt09619722
IRS990/TotalAssetsGrp/EOYAmt013356814
IRS990/TotalCompGreaterThan150KInd00
IRS990/TotalContributionsAmt03905995
IRS990/TotalEmployeeCnt00
IRS990/TotalFunctionalExpensesGrp/FundraisingAmt04676
IRS990/TotalFunctionalExpensesGrp/ManagementAndGeneralAmt054828
IRS990/TotalFunctionalExpensesGrp/ProgramServicesAmt0116181
IRS990/TotalFunctionalExpensesGrp/TotalAmt0175685
IRS990/TotalGrossUBIAmt00
IRS990/TotalLiabilitiesBOYAmt0630
IRS990/TotalLiabilitiesEOYAmt07412
IRS990/TotalLiabilitiesGrp/BOYAmt0630
IRS990/TotalLiabilitiesGrp/EOYAmt07412
IRS990/TotalNetAssetsFundBalanceGrp/BOYAmt09619092
IRS990/TotalNetAssetsFundBalanceGrp/EOYAmt013349402
IRS990/TotalOtherCompensationAmt00
IRS990/TotalOtherProgSrvcExpenseAmt00
IRS990/TotalOtherProgSrvcGrantAmt00
IRS990/TotalOtherProgSrvcRevenueAmt00
IRS990/TotalProgramServiceExpensesAmt0116181
IRS990/TotalProgramServiceRevenueAmt00
IRS990/TotalReportableCompFromOrgAmt00

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings